A randomized Phase 2a trial published in Nature Medicine demonstrated significant reductions in liver fat content in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
Common side effects include nausea, vomiting, and diarrhea, which are typically transient
Fulcher KD, Welch JE, Klapper DG et al (1995) Identification of a unique -class glutathione S-transferase in mouse spermatogenic cells
But if youre dealing with high copays, prior authorization delays, or no coverage at all, you dont have to choose between overpaying and going without treatment
Some individuals find that they reach their goals perfectly well on semaglutide with very few side effects, making it the better choice for their specific biology
Patients with type 2 diabetes and established atherosclerotic cardiovascular disease represent a particularly appropriate population for semaglutide therapy